Skip to main content
. 2016 Jun 21;2016:1363902. doi: 10.1155/2016/1363902

Figure 2.

Figure 2

The effects of pretreatment with VEGF, IGF-1, and bFGF on hypoxia-induced apoptosis of bone marrow-derived mesenchymal stromal cells (BMSCs). (a) Apoptosis analysis of BMSCs by flow cytometry; when exposed to hypoxia, BMSCs treated with IGF-1 and bFGF underwent less apoptosis compared with control (10.2 ± 1.4% and 10.7 ± 2.5% versus 26.1 ± 3.4%; P < 0.05; n = 6 in each group), while the apoptosis rate of VEGF was 20.7 ± 1.9%. (b) Apoptosis analysis of BMSCs by TUNEL assay; BMSCs with bFGF and IGF-1 showed a lower calculated apoptotic rate (17.6 ± 3.5% and 19.2 ± 6.7% versus 36.0 ± 3.7%, P < 0.05), while VEGF was 28.3 ± 3.3%; P < 0.05 versus control; n = 6 in each group. Bar scale = 80 μm.